Vident Advisory’s Apellis Pharmaceuticals APLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-14,564
Closed -$465K 1555
2024
Q4
$465K Buy
+14,564
New +$465K 0.01% 991